18 results
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
practicable, Ocuphire attempts to identify more than one supplier. However, some raw materials are available only from a single source or only one supplier
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
7 Nov 22
Ocuphire to Receive $35 Million Upfront, Nyxol Development Funding and Additional Potential Milestone Payments plus Tiered Double-Digit Royalties
4:16pm
) consistent and controlled manufacturing process(es) for the Compound or Product(s) including storage conditions for raw materials, intermediates
424B5
rt2qtxyti6m9jx2fzzy
7 Jun 21
Prospectus supplement for primary offering
4:21pm
424B5
lcekq
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
l8k4p
17 Feb 21
Prospectus supplement with pricing info
7:14am
424B3
kab y4xkft0e
2 Oct 20
Prospectus supplement
9:25am
S-4/A
fhda9w
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4
ia2lsj
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
DEFM14A
97ri8 pg3ik490s
29 Apr 05
Proxy related to merger
12:00am
- Prev
- 1
- Next